OTI Greentech Valuation
Is NSAK undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of NSAK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: NSAK (€0.06) is trading above our estimate of fair value (€0.02)
Significantly Below Fair Value: NSAK is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NSAK?
Key metric: As NSAK is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is NSAK's PS Ratio? | |
|---|---|
| PS Ratio | 0.03x |
| Sales | €17.18m |
| Market Cap | €571.01k |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.04x |
| Enterprise Value/EBITDA | -2.5x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does NSAK's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.4x | ||
IBU IBU-tec advanced materials | 0.7x | 19.2% | €33.0m |
540066 AMS Polymers | 0.09x | n/a | ₹85.1m |
CNEY CN Energy Group | 0.02x | n/a | US$1.0m |
BIG1 Bio-Gate | 0.8x | 16.3% | €6.5m |
NSAK OTI Greentech | 0.03x | n/a | €571.0k |
Price-To-Sales vs Peers: NSAK is good value based on its Price-To-Sales Ratio (0x) compared to the peer average (0.4x).
Price to Sales Ratio vs Industry
How does NSAK's PS Ratio compare vs other companies in the DE Chemicals Industry?
| 3 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| Industry Avg. | 1.0x | 4.3% | |
NSAK OTI Greentech | 0.03x | n/a | US$602.27k |
2HRA H&R GmbH KGaA | 0.1x | 2.7% | US$133.44m |
B7Y Byotrol | 0.04x | n/a | US$246.97k |
| 3 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
| Industry Avg. | 1.0x | 35.2% | |
NSAK OTI Greentech | 0.03x | n/a | US$602.27k |
Price-To-Sales vs Industry: NSAK is good value based on its Price-To-Sales Ratio (0x) compared to the European Chemicals industry average (1x).
Price to Sales Ratio vs Fair Ratio
What is NSAK's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.03x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate NSAK's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Ecora Resources
UK£159.8m
Operates as a natural resource royalty and streaming company in Australia, North and South America, Europe, and internationally.
HGR
UK£0.77
7D
8.9%
1Y
-29.0%
Central Asia Metals
UK£277.0m
Operates as a base metals producer.
9C3
UK£1.87
7D
0.5%
1Y
-4.1%
Arkema
€5.7b
Manufactures and sells specialty chemicals and advanced materials worldwide.
V1S
€75.20
7D
-2.0%
1Y
-17.2%